Premarket Research Report Covering the Medical Laboratories & Research Industry
ACCESSWIRE - Thu Jun 09, 8:17AM CDT
LONDON, UK / ACCESSWIRE / June 9, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Medical Laboratories & Research industry. Companies recently under review include Thermo Fisher Scientific, Great Basin Scientific, PerkinElmer, and Organovo. Register with us now for your free membership and see our complete reports on these equities at:
GBSN: 1.80 (+0.06), TMO: 150.52 (-1.28), ONVO: 2.89 (-0.21), PKI: 53.10 (-0.59)
Thermo Fisher Scientific Strengthens Life Sciences Leadership with New Instruments Launched at ASMS 2016
BusinessWire - Mon Jun 06, 7:00AM CDT
Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, strengthened its industry-leading analytical instruments platform with innovative systems designed to help pharmaceutical and biologics producers more efficiently discover and develop candidate drugs. These new products will be on display at the 64th Annual American Society for Mass Spectrometry (ASMS) Conference, June 5-9 in Texas Ballroom D at the Grand Hyatt Hotel.
TMO: 150.52 (-1.28)
FEI COMPANY SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Wed Jun 01, 12:21PM CDT
Rigrodsky & Long, P.A.:
TMO: 150.52 (-1.28), FEIC: 107.33 (+0.58)
FEI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FEI Company
PR Newswire - Tue May 31, 2:09PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF"
TMO: 150.52 (-1.28), FEIC: 107.33 (+0.58)
Milberg LLP Announces Investigation of Purchase of FEI Company by Thermo Fisher Scientific Inc.
PR Newswire - Tue May 31, 9:48AM CDT
Milberg LLP is investigating possible breaches of fiduciary duty and other violations of law in connection with the proposed acquisition of FEI Company (NASDAQ: FEIC) ("FEI"
TMO: 150.52 (-1.28), FEIC: 107.33 (+0.58)
Thermo Fisher to Buy FEI, Boost Electron Microscopy Platform
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:58AM CDT
The FEI deal is expected to be accretive to Thermo Fisher's (TMO) adjusted EPS by 30 cents in the first full year after close.
BSX: 22.95 (-0.07), SRDX: 23.47 (+0.28), TMO: 150.52 (-1.28), BAX: 44.41 (-0.08), FEIC: 107.33 (+0.58)
Robbins Arroyo LLP: Acquisition of FEI Company (FEIC) by Thermo Fisher Scientific Inc. (TMO) May Not Be in Shareholders' Best Interests
BusinessWire - Fri May 27, 12:49PM CDT
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of FEI Company (NASDAQ: FEIC) by Thermo Fisher Scientific Inc. (NYSE: TMO). On May 27, 2016, the two companies announced the signing of a definitive merger agreement pursuant to which Thermo Fisher will acquire FEI Company. Under the terms of the agreement, FEI Company shareholders will receive $107.50 for each share of FEI Company common stock.
TMO: 150.52 (-1.28), FEIC: 107.33 (+0.58)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of FEI Company to Thermo Fisher Scientific Inc. - FEIC
ACCESSWIRE - Fri May 27, 8:58AM CDT
NEW YORK, NY / ACCESSWIRE / May 27, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
TMO: 150.52 (-1.28), FEIC: 107.33 (+0.58)
FEI (FEIC) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of FEI Company; Are FEI Shareholders Getting a Fair Price?
PR Newswire - Fri May 27, 7:06AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of FEI Company (NASDAQ: FEIC) breached their fiduciary duties in connection with the proposed sale of the Company to Thermo Fisher Scientific Inc. (NYSE: TMO). FEI supplies scientific instruments and related services for nanoscale applications and solutions for industry and science.
TMO: 150.52 (-1.28), FEIC: 107.33 (+0.58)
Thermo Fisher Scientific to Acquire FEI Company
BusinessWire - Fri May 27, 6:00AM CDT
--Creates New Opportunities to Expand Presence in Attractive Materials Science Market
TMO: 150.52 (-1.28), FEIC: 107.33 (+0.58)
Thermo Fisher Scientific Set to Possibly Rebound After Yesterday's Selloff of 1.86%
Comtex SmarTrend(R) - Thu May 19, 2:15PM CDT
Thermo Fisher Scientific (NYSE:TMO) traded in a range yesterday that spanned from a low of $146.93 to a high of $149.56. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $147.70 on volume of 656,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TMO: 150.52 (-1.28)
Thermo Fisher Scientific Declares Quarterly Dividend
BusinessWire - Wed May 18, 3:30PM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on July 15, 2016, to shareholders of record as of June 15, 2016.
TMO: 150.52 (-1.28)
Thermo Fisher Posts Solid Q1; Affimetrix Integration Continues
Zacks Equity Research - Zacks Investment Research - Wed May 18, 6:40AM CDT
On May 18, 2016, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).
IRMD: 19.88 (-1.47), MASI: 51.66 (-0.44), TMO: 150.52 (-1.28), EW: 101.13 (-0.39)
Enzo Biochem's Life Sciences Unit Reaches $35 Million Patent Infringement Settlement in Delaware With Life Technologies Corporation
BusinessWire - Mon May 16, 3:07PM CDT
Enzo Biochem, Inc. (NYSE:ENZ) today announced that its subsidiary, Enzo Life Sciences, Inc., has reached and finalized a settlement with Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. (NYSE:TMO), involving payment of $35 million to Enzo in an action brought in Delaware Federal District Court by Enzo alleging infringement of its U.S. Patents Nos. 6,992,180 entitled Oligo- or Polynucleotides Comprising Phosphate Moiety Labeled Nucleotides and 7,064,197 entitled System, Array and Non-Porous Solid Support Comprising Fixed or Immobilized Nucleic Acids.
LIFE: 3.10 (+0.03), ENZ: 5.69 (-0.30), TMO: 150.52 (-1.28)
What Caused Illumina's Shares to Crash 19% In April
Todd Campbell, The Motley Fool - Motley Fool - Thu May 05, 7:20AM CDT
SOURCE: ILLUMINA INC. What: After pre-announcing a revenue and profit shortfall, Illumina saw its shares lose 19.1% of their value last month, according to data from S&P Global Market Intelligence . So what: The maker of instruments...
PACB: 9.80 (+0.24), TMO: 150.52 (-1.28), ILMN: 139.71 (-1.91)
Thermo Fisher Scientific to Host Analyst Meeting
BusinessWire - Wed May 04, 3:30PM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2016 Analyst Meeting on Wednesday, May 18, starting at 9:00 a.m. (EDT), at the Mandarin Oriental New York, 80 Columbus Circle at 60th Street, in New York City.
TMO: 150.52 (-1.28)
Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 10, 2016
BusinessWire - Mon May 02, 3:30PM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016, at 10:40 a.m. (PDT) at the Encore at the Wynn Las Vegas, Las Vegas, Nev.
TMO: 150.52 (-1.28)
Thermo Fisher (TMO) Beats on Q1 Earnings, Raises Outlook
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 9:14AM CDT
Thermo Fisher Scientific, Inc.'s (TMO) first-quarter 2016 adjusted earnings per share (EPS) came in at $1.80, 3.4% ahead of the Zacks Consensus Estimate.
TMO: 150.52 (-1.28), EW: 101.13 (-0.39), IDXX: 88.92 (+0.04), HOLX: 33.41 (-0.73)
Thermo Fisher (TMO) Beats Q1 Earnings, Revenue Estimates
Aparajita Dutta - Zacks Investment Research - Thu Apr 28, 6:48AM CDT
Thermo Fisher's (TMO) adjusted earnings per share of $1.80 beat the Zacks Consensus estimate by 3.4%.
TMO: 150.52 (-1.28)